ISHRAK OMAR — SEC insider filings
SEC reporting owner CIK 1523102. 39 insider filings on record with FilingPulse; latest filed 2026-11-09.
Transaction summary — filings shown
Covers all 39 filings on record, filed 2020-10-14 to 2026-11-09. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 3 legs across 3 filings — 31,111 shares, $1,460,153 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 763 shares, $82,709 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 51.
- Largest priced transaction: purchase of 20,000 shares @ $48.02 ($960,418) in INTEL CORP, filed 2021-11-01.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| INTEL CORP (INTC) | Director | 13 | 3 legs · 31,111 sh · $1,460,153 | — | 17 |
| Medtronic plc (MDT) | Executive Chairman, Director | 2 | — | 1 leg · 763 sh · $82,709 | 4 |
| AMGEN INC (AMGN) | Director | 21 | — | — | 21 |
| Compute Health Acquisition Corp. (CPUH) | Director, 10% owner | 2 | — | — | 8 |
| ALLURION TECHNOLOGIES, INC. (ALUR) | Director | 1 | — | — | 1 |
Insider filings — ISHRAK OMAR
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-11-09 | 4 | AMGEN INC (AMGN) | Grant/award (A): 152.04 @ $0 | EDGAR |
| 2026-08-10 | 4 | AMGEN INC (AMGN) | Grant/award (A): 85.17 @ $0 | EDGAR |
| 2026-05-21 | 4 | AMGEN INC (AMGN) | Grant/award (A): 665 @ $0 | EDGAR |
| 2026-05-07 | 4 | AMGEN INC (AMGN) | Grant/award (A): 106.19 @ $0 | EDGAR |
| 2025-11-12 | 4 | AMGEN INC (AMGN) | Grant/award (A): 218.61 @ $0 | EDGAR |
| 2025-08-12 | 4 | AMGEN INC (AMGN) | Grant/award (A): 121.43 @ $0 | EDGAR |
| 2025-05-28 | 4 | AMGEN INC (AMGN) | Grant/award (A): 809 @ $0 | EDGAR |
| 2025-05-08 | 4 | AMGEN INC (AMGN) | Grant/award (A): 129.42 @ $0 | EDGAR |
| 2025-04-01 | 4 | INTEL CORP (INTC) | Grant/award (A): 1,376.05 (derivative) @ $22.71 | EDGAR |
| 2024-12-31 | 4 | INTEL CORP (INTC) | Grant/award (A): 1,539.41 (derivative) @ $20.30 | EDGAR |
| 2024-11-06 | 4 | AMGEN INC (AMGN) | Grant/award (A): 220.88 @ $0 | EDGAR |
| 2024-10-01 | 4 | INTEL CORP (INTC) | Grant/award (A): 1,306.98 (derivative) @ $23.91 | EDGAR |
| 2024-08-13 | 4 | AMGEN INC (AMGN) | Grant/award (A): 108.53 @ $0 | EDGAR |
| 2024-07-02 | 4 | INTEL CORP (INTC) | Grant/award (A): 1,009.04 (derivative) @ $30.97 | EDGAR |
| 2024-06-04 | 4 | AMGEN INC (AMGN) | Grant/award (A): 719 @ $0 | EDGAR |
| 2024-05-10 | 4 | INTEL CORP (INTC) | Grant/award (A): 7,403 (derivative) | EDGAR |
| 2024-05-08 | 4 | AMGEN INC (AMGN) | Grant/award (A): 116.55 @ $0 | EDGAR |
| 2024-04-02 | 4 | INTEL CORP (INTC) | Grant/award (A): 594.29 (derivative) @ $44.17 | EDGAR |
| 2023-11-07 | 4 | AMGEN INC (AMGN) | Grant/award (A): 240.87 @ $0 | EDGAR |
| 2023-10-25 | 4 | ALLURION TECHNOLOGIES, INC. (ALUR) | Grant/award (A): 45,235 @ $0 | EDGAR |
| 2023-08-10 | 4 | INTEL CORP (INTC) | Purchase (P): 86 @ $28.05 | EDGAR |
| 2023-08-10 | 4 | AMGEN INC (AMGN) | Grant/award (A): 124.62 @ $0 | EDGAR |
| 2023-08-03 | 4/A | Compute Health Acquisition Corp. (CPUH) jointly with Compute Health Sponsor LLC, Nehme Jean, Fink Joshua A | Grant/award (A): 2,088,327 · Disposition to issuer (D): 161,379 · Disposition to issuer (D): 1,926,948 · Disposition to issuer (D): 21,442,500 (derivative) | EDGAR |
| 2023-08-03 | 4 | Compute Health Acquisition Corp. (CPUH) jointly with Compute Health Sponsor II LLC, Nehme Jean, Fink Joshua A | Grant/award (A): 2,088,327 · Disposition to issuer (D): 161,379 · Disposition to issuer (D): 1,926,948 · Disposition to issuer (D): 21,442,500 (derivative) | EDGAR |
| 2023-05-23 | 4 | AMGEN INC (AMGN) | Grant/award (A): 939 @ $0 | EDGAR |
| 2023-05-15 | 4 | INTEL CORP (INTC) | Option exercise (M): 4,828 · Grant/award (A): 7,152 (derivative) · Option exercise (M): 4,828 (derivative) | EDGAR |
| 2023-05-03 | 4 | AMGEN INC (AMGN) | Grant/award (A): 137.73 @ $0 | EDGAR |
| 2022-11-10 | 4 | AMGEN INC (AMGN) | Grant/award (A): 222.31 @ $0 | EDGAR |
| 2022-08-11 | 4 | AMGEN INC (AMGN) | Grant/award (A): 130.86 @ $0 | EDGAR |
| 2022-05-19 | 4 | AMGEN INC (AMGN) | Grant/award (A): 855 @ $0 | EDGAR |
| 2022-05-16 | 4 | INTEL CORP (INTC) | Option exercise (M): 3,720 · Grant/award (A): 4,828 (derivative) · Option exercise (M): 3,720 (derivative) | EDGAR |
| 2022-05-04 | 4 | AMGEN INC (AMGN) | Grant/award (A): 140.74 @ $0 | EDGAR |
| 2022-02-24 | 4 | INTEL CORP (INTC) | Purchase (P): 11,025 @ $45.11 | EDGAR |
| 2021-11-01 | 4 | INTEL CORP (INTC) | Purchase (P): 20,000 @ $48.02 | EDGAR |
| 2021-08-10 | 4 | AMGEN INC (AMGN) | Grant/award (A): 760 @ $0 | EDGAR |
| 2021-05-17 | 4 | INTEL CORP (INTC) | Option exercise (M): 3,721 · Option exercise (M): 3,721 (derivative) · Grant/award (A): 3,720 (derivative) | EDGAR |
| 2021-02-02 | 4 | INTEL CORP (INTC) | Option exercise (M): 810 · Option exercise (M): 810 (derivative) | EDGAR |
| 2020-12-11 | 4 | Medtronic plc (MDT) | Gift (G): 8,650 @ $0 · Gift (G): 8,650 @ $0 | EDGAR |
| 2020-10-14 | 4 | Medtronic plc (MDT) | Sale (S): 763 @ $108.40 · Gift (G): 5,900 @ $0 · Gift (G): 5,900 @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-10-13 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1523102 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs